Your browser doesn't support javascript.
loading
CAR-T cell combination therapy: the next revolution in cancer treatment.
Al-Haideri, Maysoon; Tondok, Santalia Banne; Safa, Salar Hozhabri; Maleki, Ali Heidarnejad; Rostami, Samaneh; Jalil, Abduladheem Turki; Al-Gazally, Moaed E; Alsaikhan, Fahad; Rizaev, Jasur Alimdjanovich; Mohammad, Talar Ahmad Merza; Tahmasebi, Safa.
Afiliación
  • Al-Haideri M; Department of Physiotherapy, Cihan University, Erbil, Kurdistan Region, Iraq.
  • Tondok SB; Department of Nursing, Health Polytechnic of the Ministry of Health Jayapura, Jayapura, Indonesia.
  • Safa SH; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Maleki AH; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Rostami S; School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
  • Jalil AT; Medical Laboratories Techniques Department, Al-Mustaqbal University College, Hilla, 51001, Babylon, Iraq.
  • Al-Gazally ME; College of Medicine, University of Al-Ameed, Karbala, Iraq.
  • Alsaikhan F; College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Kingdom of Saudi Arabia.
  • Rizaev JA; Department of Public Health and Healthcare Management, Rector Samarkand State Medical University, Samarkand, Uzbekistan.
  • Mohammad TAM; Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region, Iraq.
  • Tahmasebi S; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. safa.tahmasebi@sbmu.ac.ir.
Cancer Cell Int ; 22(1): 365, 2022 Nov 24.
Article en En | MEDLINE | ID: mdl-36419058

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Irak

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Irak